Ragnhild A. Lothe
- Group leader, professor
- +47 2278 1728
Department of Molecular Oncology, Institute for Cancer Research
Oslo University Hospital, Oslo, Norway
BIOGRAPHICAL SKETCH
Positions
| Head of Dept. Molecular Oncology and Group leader at the Inst. Cancer Research, OUS Professor II, Institute for Clinical Medicine, University of Oslo |
Education
| 1992 | Dr.philos (PhD) - Cancer genetics, Faculty of Medicine, U of Oslo |
| 1983 | Cand.scient (MSc) - Microbiology, Faculty of Mathematics and Natural Sciences, U of Oslo |
| 1981 | University level lecturer in Mathematics, Chemistry and Biology, Faculty of Mathematics and Natural Sciences, U of Bergen |
| 2003 | Science of higher education course, Faculty of Educational Sciences, U of Oslo |
Scientific leadership
| 2006- to date | Head of Dept. Molecular Oncology former Dept. Cancer Prevention (until 2014) |
| 2019-24 | Leader of OUH strategic research area: TEAM-ACT (Tumor Evolution in Advanced Models to Accelerate precision Cancer Therapy) |
| 2010-to date | Leader of a European multicentre project of Malignant peripheral nerve sheath tumors |
| 2014-20 | Director of K.G. Jebsen Colorectal Cancer Research Centre, Division Cancer Medicine, OUS |
| 2014-18 | Leader of OUH priority area: S.MA.R.T – colorectal cancer |
| 2012-19 | WP leader and PI in The Norwegian Cancer Genomics Consortium |
| 2007-17 | Co-director of Norwegian Centre of Excellence - Cancer Biomedicine, U of Oslo |
Young scientist positions and research stays
| 1997-2006 | Group leader, Department of Genetics, Norwegian Radium Hospital (NRH) |
| 1995 | Guest scientist in Prof. Olli Kallioniemi lab., Tampere University Hospital, FIN (1month) |
| 1995-97 | Research scientist, personal grant from the Norwegian Cancer Society |
| 1993-2001 | Consultant in Molecular diagnostics (side position), Dept. Pathology, NRH |
| 1993 | Post doc stay in Prof. Albert de la Chapelle lab., U of Helsinki, FIN (2months) |
| 1992-94 | Independent postdoctoral fellowship, the Research Council of Norway |
| 1986-92 | PhD student; including a stay in Prof. Ray White lab., Howard Hughes Medical Institute, Salt Lake City, U of Utah, USA (8months). Supervisor: Prof. Tobias Gedde-Dahl jr. |
Prizes and honours
| 2024 | Recipient of the Medal of Merit - Gold grade from the Porto Municipal, Portugal |
| 2021 | Excellent Researcher Award – Oslo University Hospital |
| 2018- | Honorary member of the European Association for Cancer Research |
| 2018- | Honorary associate investigator of Centre for Molecular Medicine Norway (NCMM) |
| 2014 | Medical Research Centre award (director), K.G. Jebsen Foundation Norway |
| 2012-19 | National honors (5) in science, from OUH and the South-East Regional Health Authorities |
| 2011 | Invited speaker to The Royal Swedish Academy of Sciences, Stockholm |
| 2008 | Invited speaker on the occasion of a Royal State Visit to Portugal, U of Porto |
| 2007 | Recipient of the Technical Transfer Office – Medinnova’s (OUH) idea prize |
| 2007 | Elected member of The Norwegian Academy of Science and Letters |
| 2007 | King Olav V’s Prize for Cancer Research |
| 2003 | Ragnar Mørk’s prize for excellent cancer research |
| 1998, 02 | Young researcher prizes: Radium Hospital, Inst. for Cancer Research |
Supervision, mentoring
| 2001-to date | 36 completed PhDs, 28 MSc, 22 post docs/staff scientists |
Commisions of trust (selected)
| 2020-23 | Scientific committee member for two EACR-OECI joint conferences: "Molecular Pathology Approach to Cancer", March 2023, Bergamo, Italy and as virtual conference 2021 |
| 2017-to date | Board of directors for Inven2, innovation Company owned by the U of Oslo and OUH |
| 2015-19 | BIOTEK2021-programme board, appointed by Division for Innovation, RCN |
| 2014,15,16 | RA Lothe and PE Lønning, scientific organizers of the 1st, 2nd, 3rd National Conference in Cancer Genomics, Losby, Norway |
| 2014-to date | Editorial board, BBA-Reviews on Cancer, Elsevier Publisher |
| 2013-17 | Deputy chair of the "Nasjonal kreftsatsing – helseregionene" |
| 2011-17 | Elected national representative in the Council of the European Association for Cancer Research |
| 2008-17 | Chair of the board, Centre for Molecular Medicine Norway, Nordic EMBL Partnership |
| 2008-16 | Elected member of the Board of Norwegian Centre of Expertise, Oslo Cancer Cluster |
| 2008-11 | Chair of the Research Council, the Norwegian Cancer Society |
| 2006-11 | Member of the Norwegian Board of Forensic Medicine; Appointed by the Norwegian Ministry of Justice and Public Security |
| 2000-07 | Chair of the grant evaluation committee in basic science, Norwegian Cancer Society |